P. Rudolph et al., IMMUNOPHENOTYPE, PROLIFERATION, DNA-PLOIDY, AND BIOLOGICAL BEHAVIOR OF GASTROINTESTINAL STROMAL TUMORS - A MULTIVARIATE CLINICOPATHOLOGICALSTUDY, Human pathology, 29(8), 1998, pp. 791-800
To determine the prognostic impact of clinical, immunohistochemical, a
nd biological parameters, we examined 52 gastrointestinal stromal tumo
rs (GIST) by conventional light microscopy and immunohistochemistry. D
NA ploidy was analyzed by image cytometry on cytospin preparation. The
proliferative activity was determined by mitosis counting and assessm
ent of Ki-67 reactivity by means of monoclonal antibody Ki-S5. A histo
pathologic grade was assigned to each tumor according to the French Fe
deration of Cancer Centers (FNCLCC) grading system. Next to vimentin,
CD34 was the most prevalent antigen, followed by markers of neural and
muscular differentiation. Many tumors exhibited a mixed phenotype. Tw
enty-one tumors were diploid, eight hypodiploid, and 23 aneuploid. In
univariate analysis, tumor grade, Ki-S5 labeling index, mitotic count,
atypical mitoses, cellularity, and sex were predictive of both mortal
ity and metastasis risk. DNA ploidy only correlated with overall survi
val, whereas the tumor location affected the occurrence of metastases.
Multivariate analysis selected Ki-S5 scores (P < .0001) and atypical
mitoses (P = .012) as independent prognosticators for overall survival
, and tumor grade (P = .0036) and size (P = .0055) as predictors of me
tastatic spread. We conclude that GIST are primitive mesenchymal tumor
s capable of divergent differentiation, which does not influence their
prognosis. The latter appears to be best predicted by histopathologic
grading and the Ki-67 labeling index. Copyright (C) 1998 by W.B. Saun
ders Company.